Scoop: Just months af­ter Sanofi AI deal, Atom­wise laid off 30% of staffers amid 's­trate­gic shift'

Atom­wise, a well-con­nect­ed play­er in the bur­geon­ing space of ar­ti­fi­cial in­tel­li­gence-pow­ered drug dis­cov­ery, cut its head­count by 30% in De­cem­ber, End­points News has learned.

CEO and co-founder Abra­ham Heifets con­firmed the lay­offs, which re­sult­ed in around 30 peo­ple de­part­ing the com­pa­ny.

“We had to make some very hard de­ci­sions and part ways with some fan­tas­tic col­leagues,” he wrote in an email.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER